Delee
Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.
Y Combinator
yc-company-directory #3750Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.
sourceDelee is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Delee
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
allumbra
match 58allumbra develops a blood test for oncologists and cancer centers that uses photonics and AI to detect early cancer recurrence in head and neck cancer survivors, addressing the need for accurate and affordable monitoring in a market with limited options
shared extracted concept terms: monitor; shared product terms: develop, blood, test, cancer
OncoRevive
match 55Revolutionizing cancer care with AI-powered liquid biopsy for early detection and personalized treatment.
shared extracted concept terms: treatment; shared product terms: blood, test, early, cancer; shared product theme: health and clinical care
Notable Labs
match 49Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single dr
shared product terms: blood, test, cancer, treatment; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
BillionToOne
match 46BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the
shared product terms: develop, cell, cancer, test; shared product theme: health and clinical care; shared affiliation: Y Combinator
Makani Science
match 40Makani Science is a medical device company based in Irvine, California. We have created the world's first wireless patch that can accurately and continuously monitor breathing. The company is co-founded by Dr. Michelle Khine and Dr. Michael Chu, two experts in the wearable monitoring space from the University of California, Irvine. The Makani Science system will collect unique breathing waveforms from patients in everyday environments to create the first large database of respiratory patterns as
shared extracted concept terms: monitor; shared product terms: medical, device, monitor; shared product theme: health and clinical care; shared affiliation: Y Combinator
Enermo Technology
match 34Enermo is a Condition Monitoring platform which predict faults in Induction Motors and associated drives at very early stages by electrical signature analysis
shared extracted concept terms: monitor; shared product terms: monitor, early, analysi